Copenhagen, Denmark - A team of Danish researchers have shown that certain patients with congestive heart failure (CHF) may benefit from the class III antiarrhythmic drug dofetilide (Tikosyn? - Pfizer ...

Tyrosine kinase inhibitors (TKIs) are associated with prolongation of the QTc interval on the electrocardiogram (ECG). The QTc-interval prolongation increases the risk of life-threatening arrhythmias.

ROTTERDAM, the NETHERLANDS — A new analysis of participants in a population-based cohort study suggests at least two ECGs might be useful to stratify individuals at risk for sudden cardiac death (SCD) ...

There were 252 patients with EKG results included for the analysis; they were given concomitant therapy for median 7 days. This article is written live from ID Week 2017 Annual Meeting in San Diego, ...

To examine gender differences in rate-corrected QT interval (QTc), an index of ventricular depolarization/repolarization, in young, trained men and women with lower ...

NEW ORLEANS, LA— Supratherapeutic plasma levels of dabigatran etexilate do not prolong QTc intervals of the electrocardiogram (ECG), as reported from a study presented at ACC.11, the American College ...

(HealthDay News) — In combination with risk factors, QTc interval-prolonging medications (QTPMs) are associated with greater QTc lengthening than QTPMs alone, according to a study published online in ...

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: ...

Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...

Aim To determine factors affecting the QT interval in athletes and find an improved means of QT correction (QTc) Method Data was gathered from the CAYA (Cardiovascular Assessment in Young Athletes) ...

AliveCor has received clearance for its portable ECG to calculate a patient’s QTc Interval. This FDA action follows the enforcement policy for non-invasive devices issued by the agency in March 2020 ...